Traditional Chinese Medicine Unveils Multi-Target Mechanism for Rosacea Treatment
Background
Rosacea is a chronic inflammatory skin condition characterized by facial redness, visible blood vessels, and papules, significantly impacting quality of life. Current treatments often have limited efficacy or side effects, highlighting an unmet need for novel therapeutic strategies. This study aimed to systematically elucidate the underlying molecular mechanisms of Cuochuangling Pills, a traditional Chinese medicine, in treating rosacea using an integrated computational and experimental approach.
Results
The network pharmacology analysis predicted 18 active compounds in Cuochuangling Pills and identified 156 potential targets, with the TLR4/NF-κB signaling pathway emerging as a central regulatory mechanism for rosacea inflammation. In vitro studies confirmed that Cuochuangling Pills significantly suppressed inflammatory responses in stimulated keratinocytes, reducing the expression of pro-inflammatory cytokines such as IL-6 by 43% and TNF-α by 37% compared to untreated controls (p<0.01). In the mouse model of rosacea, treatment with Cuochuangling Pills led to a significant reduction in facial erythema (redness) by 35% and a 42% decrease in papule count compared to the control group (p<0.001). Immunohistochemical analysis of skin biopsies revealed a 2.8-fold decrease in TLR4 protein expression and a 2.1-fold reduction in activated NF-κB in the treated mice, directly correlating with the observed clinical improvements. Furthermore, the treatment group showed a 1.9-fold increase in antioxidant enzyme activity.
Why It Matters
This comprehensive study provides a strong scientific basis for the traditional use of Cuochuangling Pills in treating rosacea, elucidating its multi-target anti-inflammatory and antioxidant mechanisms. The identification of the TLR4/NF-κB pathway as a key target suggests a promising new therapeutic strategy that could lead to more effective and holistic treatments for this chronic skin condition. Future research should focus on isolating the most potent active compounds and conducting rigorous human clinical trials (e.g., Phase II studies) to confirm efficacy and safety in patients.